Weber, C., Most, P., Pleger, S. T., Krautz, B., Schlegel, P., Raake, P., . . . Müller, O. J. (2014). Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model. Gene therapy, 21(2), .
Chicago-Zitierstil (17. Ausg.)Weber, Christophe, et al. "Therapeutic Safety of High Myocardial Expression Levels of the Molecular Inotrope S100A1 in a Preclinical Heart Failure Model." Gene Therapy 21, no. 2 (2014).
MLA-Zitierstil (9. Ausg.)Weber, Christophe, et al. "Therapeutic Safety of High Myocardial Expression Levels of the Molecular Inotrope S100A1 in a Preclinical Heart Failure Model." Gene Therapy, vol. 21, no. 2, 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.